Dr. Mirat Shah, MD

  • Baltimore, MD
  • Medical oncologist
NPI1457619355
Part D claims, 2017
13
Publications
29
Industry payments
$101
State license
1
Year NPI issued
2012
Practice address
201 N Broadway St Bldg Rm10291, Baltimore, MD 21287-0031
Practice phone
Call (443) 287-6489
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Find Dr. Shah's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Mirat Shah is a medical oncologist in Baltimore, Maryland

Dr. Shah practices in Baltimore, Maryland.

Dr. Shah's NPI, 1457619355, was assigned on April 27, 2012. Dr. Shah holds Maryland license D79787.

NPI and contact details
NPI enumeration date
April 27, 2012
NPI status
Active
Practice phone
(443) 287-6489
Professional email
Get email
Personal email
Get email
Mobile number
Get number

Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data

Dr. Mirat Shah's practice address is in Baltimore, Maryland

Dr. Shah's practice address in the NPI Registry is 201 N Broadway St Bldg Rm10291, Baltimore, MD 21287-0031. The practice phone is (443) 287-6489.

  • NPI Registry address
    201 N Broadway St Bldg Rm10291, Baltimore, MD 21287-0031Phone(443) 287-6489

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dmand AI tracks the EHR system at Dr. Mirat Shah's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shah practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Dr. Shah's practiceAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Shah practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Mirat Shah is one of 157 medical oncologists in Maryland

Medical oncology is Dr. Shah's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Shah is licensed in Maryland.

Specialties and state licenses

  • Medical oncology, MarylandPrimaryLicense D79787 · taxonomy 207RX0202X

Medical oncologists near Dr. Shah

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Mirat Shah wrote 13 Medicare Part D claims in 2017

In 2017, Dr. Shah wrote 13 Medicare Part D claims. They cover 1 drug, with $172,756 in total drug cost. In 2016, CMS named 12 claims across 1 drug.

Part D claims, 201713
Drugs named by CMS1
Total drug cost$172,756

Dr. Shah's most prescribed drugs by claims, 2017

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2016 to 2017

  • 2016
  • 2017
Claims for drugs CMS names
2016: 122017: 138%

Drugs named by CMS: 1 in 2017, 1 in 2016.

See all prescribing by Dr. Shah

Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Shah by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Mirat Shah has 29 publications on record

Dmand AI links 29 papers to Dr. Shah, published from 2016 to 2025. 2025 was the busiest year, with 5. The most frequent topics are United States Food and Drug Administration, Antineoplastic Agents and Drug Approval. Dr. Shah has published most often in Clin Cancer Res. Dr. Shah's most frequent co-authors are Marc Robert Theoret, MD, Paul G. Kluetz, MD and Christy Lynn Osgood, MD.

Papers29
Years published2016 to 2025

Dr. Shah's papers by year, 2016 to 2025

Topics Dr. Shah writes about most

  • United States Food and Drug Administration
  • Antineoplastic Agents
  • Drug Approval
  • Breast Neoplasms
  • Drug Development
  • Medical Oncology
  • Receptor, ErbB-2
  • Antineoplastic Combined Chemotherapy Protocols

Dr. Shah's most frequent co-authors

Recent publications by Dr. Shah

See all 29 publications and co-authors

See who Dr. Shah researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Shah works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Mirat Shah received $101 in industry payments in 2019

CMS Open Payments shows 1 general payment to Dr. Shah from 1 drug or device company in 2019. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $101.

Companies that paid Dr. Shah the most, 2019 to 2019

Share is of all general payments to this clinician.

See all payments to Dr. Shah

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Mirat Shah's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Mirat Shah

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Mirat Shah's NPI number?

Dr. Mirat Shah's NPI number is 1457619355. It was assigned on April 27, 2012, and it is active in the NPI Registry.

What kind of doctor is Dr. Mirat Shah?

Dr. Mirat Shah is a medical oncologist in Baltimore, Maryland. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Mirat Shah practice?

Dr. Shah practices at 201 N Broadway St Bldg Rm10291, Baltimore, MD 21287-0031.

What is Dr. Mirat Shah's office phone number?

The practice phone on file for Dr. Shah is (443) 287-6489.

What is Dr. Mirat Shah's medical license number?

Dr. Shah holds Maryland license D79787.

What drugs does Dr. Mirat Shah prescribe most?

In 2017 Medicare Part D data, Dr. Shah's most prescribed drugs by claims were Afinitor.

Has Dr. Mirat Shah received payments from drug or device companies?

CMS Open Payments shows $101 in general payments to Dr. Shah from 1 company from 2019 to 2019. The largest total came from Boston Scientific Corporation.

How long has Dr. Mirat Shah been practicing?

Dr. Shah's NPI was assigned in 2012.

Does Dr. Mirat Shah do research?

Dmand AI links 29 publications to Dr. Shah, published from 2016 to 2025.

Who does Dr. Mirat Shah publish with?

Dr. Shah's most frequent co-authors are Marc Robert Theoret, MD (9 shared papers), Paul G. Kluetz, MD (4 shared papers) and Christy Lynn Osgood, MD (3 shared papers).

Selling to medical oncology practices?

See medical oncologists in Maryland by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)